4basebio PLC (88Q.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 90.64M |
| Enterprise Value | 89.34M |
| P/E Ratio | -4.77 |
| PEG Ratio | 0.38 |
| Price/Sales Ratio | 47.56 |
| Price/Book Ratio | 7.99 |
| Enterprise/Revenue | 46.79 |
| Enterprise/EBITDA | -5.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -9.99 |
| Operating Margin | -9.88 |
AD
Management Effectiveness
| Return On Assets | -0.57 |
| Return On Equity | -1.16 |
Income Statement
| Revenue | 1.69M |
| Revenue/Share | 0.11 |
| Gross Profit | 548,348 |
| EBITDA | -15.59M |
| Net Income | -16.92M |
| Diluted EPS | -1.09 |
Balance Sheet
| Total Cash | 17.81M |
| Total Cash/Share | 1.15 |
| Total Debt | 16.52M |
| Total Debt/Equity | 1.63 |
| Current Ratio | 7.31 |
| Book Value Per Share | 0.65 |
Price History
| 52-Week Change | -44.35 |
| 52-Week High | 12 |
| 52-Week Low | 4.64 |
| Moving Average 50 Days | 5.76 |
| Moving Average 200 Days | 6.93 |
Statistics
| Average Volume | 359 |
| Shares Outstanding | 15.48M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
